Y-mAbs Therapeutics, Inc. YMAB
8.61 0.00 (+0.00%)
At closeSep 16, 2025, 4:00 PM EDT
8.61 Day range 8.61
8.59 52-week range 8.61
YMAB revenue history
Revenue is income from the company’s ordinary business activities.
87,685,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 87,685,000 | 2,866,000 | 3.38% |
| FY 2023 | 2023-12-31 | 84,819,000 | 19,552,000 | 29.96% |
| FY 2022 | 2022-12-31 | 65,267,000 | 30,370,000 | 87.03% |
| FY 2021 | 2021-12-31 | 34,897,000 | 14,147,000 | 68.18% |
| FY 2020 | 2020-12-31 | 20,750,000 | 20,750,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-08-15T15:34:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.